Medication Adherence Data
Buy and sell medication adherence data data. Refill gaps, PDC scores, abandonment rates — adherence AI needs real-world evidence that patients stop taking meds.
No listings currently in the marketplace for Medication Adherence Data.
Find Me This Data →Overview
What Is Medication Adherence Data?
Medication adherence data captures real-world evidence of patient medication-taking behavior, including refill gaps, Proportion of Days Covered (PDC) scores, and prescription abandonment rates. This data is critical for adherence AI systems, healthcare providers, and pharmaceutical companies to understand why and when patients stop taking medications. The global medication adherence software market is experiencing rapid growth, driven by rising chronic disease prevalence, aging populations, and the need to reduce preventable hospitalizations and healthcare costs. Advanced products integrate data from wearables, electronic health records, and connected devices, applying machine learning to identify non-adherence patterns and enable personalized interventions.
Market Data
$1.63B to $1.96B at 19.9% CAGR
AI-Enhanced Adherence Sensor Market Growth (2024–2025)
Source: Research and Markets
$6.53 billion
Medication Adherence Software Market Size (2025)
Source: DataInsights Market
$8.4B to $19.7B at 9.9% CAGR
Medication Reminder Devices Market (2025–2034)
Source: DataIntelo
Approximately 50% of patients do not take medications as prescribed
Non-Adherence Rate in Chronic Illness
Source: DataIntelo
Who Uses This Data
What AI models do with it.do with it.
Pharmaceutical Manufacturers
Use adherence data to design patient support programs, structure outcomes-based contracts with payers, and subsidize device costs to improve medication compliance and clinical trial enrollment.
Healthcare Providers & Payers
Monitor patient adherence patterns through analytics dashboards to adjust treatment plans, reduce preventable hospitalizations, and optimize resource allocation.
Digital Health & Software Companies
Build AI-powered platforms that integrate adherence data from wearables and EHRs to deliver personalized interventions and improve patient engagement across cloud-based and on-premise deployments.
Clinical Researchers
Leverage real-world adherence evidence in clinical trials and health outcomes research to validate treatment efficacy and support regulatory submissions.
What Can You Earn?
What it's worth.worth.
Individual/Single-User License
$4,900 USD
Entry-level access to medication adherence software reports and analytics.
Multi-User License
Pricing varies based on volume, exclusivity, and licensing terms
Note: Market research reports about this category typically run several thousand dollars, but actual data licensing prices are negotiated case-by-case based on volume, freshness, and exclusivity.
Enterprise License
Pricing varies based on volume, exclusivity, and licensing terms
Note: Market research reports about this category typically run several thousand dollars, but actual data licensing prices are negotiated case-by-case based on volume, freshness, and exclusivity.
What Buyers Expect
What makes it valuable.valuable.
Data Privacy & Regulatory Compliance
Data must meet HIPAA, GDPR, and emerging software-as-a-medical-device (SaMD) frameworks. Buyers require stringent data security protocols, particularly for on-premise solutions handling sensitive patient information.
Real-World Evidence Quality
Adherence metrics (refill gaps, PDC scores, abandonment rates) must be derived from verified pharmacy claims, electronic health records, or connected devices with clear audit trails and clinical validation.
EHR & Wearable Integration
Data should seamlessly integrate with existing electronic health record systems and connected medical devices (smart pill bottles, wearables) to enable comprehensive monitoring and analytics.
Actionable Analytics
Providers expect dashboards and AI-driven insights that identify non-adherence patterns early and support personalized intervention recommendations for improved patient outcomes.
Companies Active Here
Who's buying.buying.
Leading medication reminder device and adherence software provider; competitive landscape leader in 2025.
Major player in medication adherence software; involved in partnerships and platform development.
Develops AI-powered medication adherence solutions integrating computer vision and behavioral analytics.
Large healthcare technology and pharmaceutical distributor with medication adherence software offerings.
Competitive leaders in medication reminder devices and connected adherence platforms.
FAQ
Common questions.questions.
What exactly is medication adherence data and why do buyers need it?
Medication adherence data consists of refill gaps, Proportion of Days Covered (PDC) scores, prescription abandonment rates, and behavioral indicators showing when and why patients stop taking medications. Buyers—including pharmaceutical companies, healthcare providers, and AI developers—need this data to build predictive models, design patient support programs, optimize treatment plans, and reduce preventable hospitalizations driven by non-adherence. Approximately 50% of patients with chronic illnesses do not adhere to prescribed medications, making real-world evidence essential for improving outcomes.
What market growth can I expect in medication adherence data?
The medication adherence software market is projected to reach $6.53 billion by 2025 with an 8.37% CAGR through 2033. The AI-enhanced medication adherence sensor market is growing at 19.9% annually (2024–2025), and the broader medication reminder devices market is expanding from $8.4 billion in 2025 to $19.7 billion by 2034 at 9.9% CAGR. Growth is driven by aging populations, rising chronic disease prevalence, and expanding digital health adoption.
Who are the main buyers of medication adherence data?
Primary buyers include pharmaceutical manufacturers (for outcomes-based contracts and clinical trials), healthcare providers and payers (for patient monitoring and treatment optimization), digital health software companies building AI-powered platforms, and clinical researchers. Reimbursement expansion for connected adherence devices under new SaMD frameworks is also broadening institutional procurement demand.
What quality and compliance standards must adherence data meet?
Data must comply with HIPAA, GDPR, and emerging software-as-a-medical-device (SaMD) regulatory frameworks. It must integrate seamlessly with electronic health record systems and connected devices, provide verifiable metrics from pharmacy claims or wearables, maintain robust audit trails, and deliver actionable analytics through provider dashboards. Data privacy and secure handling are critical, especially for on-premise solutions managing sensitive patient information.
Sell yourmedication adherencedata.
If your company generates medication adherence data, AI companies are actively looking for it. We handle pricing, compliance, and buyer matching.
Request Valuation